How have CELC and IDYA total returns compared?

Over the past 5 years, CELC delivered 34.40% and IDYA delivered 7.32% annualized total return. Past performance doesn't predict future results.

Celcuity Inc. (CELC) vs IDEAYA Biosciences, Inc. (IDYA)

A side-by-side comparison of Celcuity Inc. and IDEAYA Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CELC

Celcuity Inc.

$3.50B

$71.71HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

IDYA

IDEAYA Biosciences, Inc.

$3.48B

$36.64HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

Total return — CELC vs IDYA

growth of $100 · dividends reinvested · last 7y

CELC +216.0% (+17.9%/yr)IDYA +240.1% (+19.1%/yr)IDYA compounded faster over this window

CELC IDYA

CELC vs IDYA: by the numbers

•CELC is the larger company ($3.50B vs $3.48B market cap).
•Both run net losses; CELC's is the smaller (0.00% vs -74.75% net margin).

Metrics side by side

Valuation

Metric	CELC	IDYA
P/S ratio	N/A	14.88
P/B ratio	N/A	2.91

Profitability

Metric	CELC	IDYA
Gross margin	0.00%	-43.89%
Operating margin	0.00%	-72.84%
Net margin	0.00%	-74.75%
ROE	N/A	-14.60%
ROIC	-28.15%	-17.68%

Growth (annualized)

Metric	CELC	IDYA
Revenue CAGR (5Y)	N/A	45.80%
Total return CAGR (5Y)	34.40%	7.32%

Frequently asked

How have CELC and IDYA total returns compared?: Over the past 5 years, CELC delivered 34.40% and IDYA delivered 7.32% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CELC analysis Full IDYA analysis Interactive comparison tool

Dig into the metrics

Celcuity ROE IDEAYA Biosciences ROE Celcuity operating margin IDEAYA Biosciences operating margin Celcuity revenue growth IDEAYA Biosciences revenue growth Celcuity free cash flow IDEAYA Biosciences free cash flow

Celcuity & IDEAYA Biosciences appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.